SavedAdd your journal

Journals / Türkiye Biyoetik Dergisi / 2026 / Cilt: 12 Sayı: 1

Hesitations, Views and Experiences of Pregnant Women Infected with COVID-19 About Vaccines: A Qualitative Study

COVID-19 ile Enfekte Olmuş Gebe Kadınların Aşıya Yönelik Tereddütleri, Görüşleri ve Deneyimleri: Türkiye’den Nitel Bir Çalışma

Rukiye Sülü Dursun(ÇUKUROVA ÜNİVERSİTESİ, SAĞLIK BİLİMLERİ ENSTİTÜSÜ)0000-0003-1093-4635
Ebru Gözüyeşil(ÇUKUROVA ÜNİVERSİTESİ, SAĞLIK BİLİMLERİ FAKÜLTESİ)0000-0002-9193-2182
Şule Gökyıldız Sürücü(ÇUKUROVA ÜNİVERSİTESİ, SAĞLIK BİLİMLERİ FAKÜLTESİ)0000-0002-0088-4219
Burcu Avcıbay(ÇUKUROVA ÜNİVERSİTESİ, SAĞLIK BİLİMLERİ FAKÜLTESİ)0000-0003-2467-5101
Pages
51–63
Publication Date
2025-03-26
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The results showed that pregnant women experienced fear due to distrust of vaccines, beliefs about the inadequacy of vaccine research, and concerns about fetus health, while those who were infected reported to experience severe symptoms and develop positive attitudes toward vaccines when they communicated with the health personnel.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Objective: Drug and vaccine studies have been carried out to control the COVID-19 pandemic, which has affected the whole world.
📊
Key Findings & Data:With the development of COVID-19 vaccines and their widespread use in countries, rates of severe illness and death have decreased.
💡
Conclusion & Impact:Conclusion: The results showed that pregnant women experienced fear due to distrust of vaccines, beliefs about the inadequacy of vaccine research, and concerns about fetus health, while those who were infected reported to experience severe symptoms and develop positive attitudes toward vaccines when they communicated with the health personnel.
🔬Design:Araştırma Makalesi
📍Scope:Comprehensive Sample
⚙️Variables:Covid-19 · tıp etiği · gebe kadın

Abstract

Background and Objective: Drug and vaccine studies have been carried out to control the COVID-19 pandemic, which has affected the whole world. With the development of COVID-19 vaccines and their widespread use in countries, rates of severe illness and death have decreased. Since pregnant women have a higher risk of hospitalization and severe disease, the most effective method of protection against COVID-19 infection is vaccination. However, with the pandemic, the impact of the epidemic on vaccine studies, access to vaccines, supply and distribution, determination of priority groups, patent problems in vaccines, vaccine hesitancy or opposition constitute the main ethical problem groups. This study utilized a qualitative study design to determine the vaccine-related hesitations, views and experiences of pregnant women who were infected with COVID-19 in Turkiye. Material and Methods: Eighteen women infected with COVID-19 were interviewed using the semi-structured interview technique. Results: The data obtained were analyzed using qualitative thematic and content analysis methods, which revealed 3 main themes and 7 sub-themes. The main themes were determined as Fear (1), Experiences (2), and Social Support (3). Conclusion: The results showed that pregnant women experienced fear due to distrust of vaccines, beliefs about the inadequacy of vaccine research, and concerns about fetus health, while those who were infected reported to experience severe symptoms and develop positive attitudes toward vaccines when they communicated with the health personnel. Besides, partner support was found to be effective in developing positive attitudes toward vaccines.

Özet

Arka Plan ve Amaç: Tüm dünyayı etkisi altına alan COVID-19 pandemisini kontrol altına almak amacıyla ilaç ve aşı çalışmaları yapılmıştır. COVID-19 aşılarının geliştirilmesi ve ülkelerce yaygın kullanıma girmesi ile beraber ağır hastalık ve ölüm oranları azalmıştır. Gebe kadınlarda hastaneye yatış ve ağır hastalık görülme riski daha yüksek olduğu için COVID-19 enfeksiyonuna karşı en etkili korunma yöntemi aşılardır. Ancak pandemiyle birlikte salgının aşı çalışmalarına etkisi, aşıya erişim, tedarik ve dağıtım, öncelikli grupların belirlenmesi, aşılarda patent sorunu, aşı kararsızlığı veya karşıtlığı başlıca etik sorun kümelerini oluşturmaktadır. Bu çalışma, Türkiye’de COVID-19 ile enfekte olmuş gebe kadınların aşıya yönelik görüşleri, deneyimleri ve tereddütlerini belirlemek amacıyla nitel çalışma deseninde yürütülmüştür. Gereç ve Yöntem: Yarı yapılandırılmış görüşme tekniği kullanılarak 18 COVID-19 ile enfekte olmuş gebe kadın ile görüşme sağlanmıştır. Bulgular: Elde edilen veriler nitel tematik ve içerik analizi ile değerlendirilmiştir. Çalışmanın içerik analizi sonucunda 3 ana tema ve 7 alt tema belirlenmiştir. Belirlenen ana temalar şunlardır: (1) Korku, (2) Deneyimler, (3) Sosyal destek. Her tema ayrı ayrı tartışılmıştır. Sonuç: Bu çalışma sonucunda, gebe kadınların, aşıya karşı güvensizlik, aşı çalışmalarının yetersiz olduğuna inanma ve fetal sağlığa ilişkin kaygılar nedeniyle korku yaşamıştır. COVID-19 ile enfekte olmuş gebe kadınların semptomları ağır yaşama ve sağlık profesyonelleri ile iletişim kurduklarında aşıya yönelik olumlu tutum geliştirmiştir. Ayrıca aşıya karşı olumlu tutum geliştirmesinde sosyal medyanın ve eş desteğinin etkili olduğu belirlenmiştir.

🔖

Cite This Article

Dursun, R. S., Gözüyeşil, E., Sürücü, Ş. G., Avcıbay, B. (2025). Hesitations, Views and Experiences of Pregnant Women Infected with COVID-19 About Vaccines: A Qualitative Study. Türkiye Biyoetik Dergisi, Cilt: 12 Sayı: 1, 51–63. https://ajindex.com/articles/1662685

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (31)

  1. Goodman T. Update on Who Interim recommendations on COVID-19 vaccination of pregnant and lactating women. World Health Organization (WHO), AFRO Webinar, June 2, 20221. Available from: https://www.who.int/publications/m/item/update-on-who-interim-recommendations-on-covid-19-vaccination-of-pregnant-and-lactating-women [cited: 2022 Nov 6]
  2. Coronavirus disease (COVID-19): Vaccines and vaccine safety. World Health Organization (WHO), 2021. Timeline: COVID-19 Vaccine Uptedates. Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-(covid-19) [cited: 2022 Nov 6]
  3. WHO Health Emergencies Programme: WHO COVID-19 Dashboard. World Health Organization (WHO), 2022. Available from: https://data.who.int/dashboards/covid19/cases [cited: 2022 Jan 26]
  4. Yokoyama A, Suzuki H, Kataoka H, Mori Y, Watanabe Y, Miyatake N. Comparison of Impressions of COVID-19 Vaccinations Stratified by the Number of Vaccinations Among Japanese Healthcare Professional University Students. Cureus, 2024; 16(3):e55861. https://doi.org/10.7759/cureus.55861.
  5. Eberhardt J, Ling J. Predicting COVID-19 Vaccination Intention Using Protection Motivation Theory and Conspiracy Beliefs. Vaccine, 2021; 39(42):6269-6275. https://doi.org/10.1016/j.vaccine.2021.09.010
  6. Galanis P, Vraka I, Siskou O, Konstantakopoulou O, Katsiroumpa A, Kaitelidou D. Uptake of COVID-19 Vaccines Among Pregnant Women: A Systematic Review and Meta-Analysis. Vaccines, 2022;10(5):766. https://doi.org/10.3390/vaccines10050766
  7. Gencer H, Özkan S, Vardar O, Serçekuş P. The Effects of the COVID 19 Pandemic on Vaccine Decisions in Pregnant Women. Women and Birth, 2022;35(3):317-323. https://doi.org/10.1016/j.wombi.2021.05.003
  8. Januszek SM, Faryniak-Zuzak A, Barnaś E, Łoziński T, Góra T, Siwiec N, Szczerba P, Januszek R, Kluz T. The Approach of Pregnant Women to Vaccination Based on a COVID-19 Systematic Review. Medicina (Kaunas), 2021;57(9):977. https://doi.org/10.3390/medicina57090977
  9. Vitiello A, Ferrara F, Zovi A, Trama U, Boccellino, M. Pregnancy and COVID-19, Focus on Vaccine and Pharmacological Treatment. J Reprod Immuno, 2022;151:103630. https://doi.org/10.1016/j.jri.2022.103630
  10. Melo GC, Araújo KCGM. COVID-19 Infection in Pregnant Women, Preterm Delivery, Birth Weight, and Vertical Transmission: A Systematic Review and Meta-Analysis. Cadernos de Saúde Pública. 2020;36(7):e00087320. https://doi.org/10.1590/0102-311X00087320
  11. Atmar RL, Lyke KE, Deming ME, Jackson LA, Branche AR, El Sahly HM, Rostad CA, Martin JM, Johnston C, Rupp RE, Mulligan MJ, Brady RC, Frenck RW, Bäcker M, Kottkamp AC, Babu TM, Rajakumar K, Edupuganti S, Dobrzynski D, Coler RN, Posavad CM, Archer JI, Crandon S, Nayak SU, Szydlo D, Zemanek JA, Dominguez Islas CP, Brown ER, Suthar MS, McElrath MJ, McDermott AB, O’Connell SE, Montefiori DC, Eaton A, Neuzil KM, Stephens DS, Roberts PC, Beigel JH. Homologous and Heterologous COVID-19 Booster Vaccinations. New England J Med, 2022;386(11):1046-1057. https://doi.org/ 10.1056/NEJMoa2116414
  12. Moghadas SM, Vilches TN, Zhang K, Nourbakhsh S, Sah P, Fitzpatrick MC, Galvani AP. Evaluation of COVID-19 Vaccination Strategies with a Delayed Second Dose. PLoS Biol, 2021;19(4):e3001211. https://doi.org/10.1371/journal.pbio.3001211
  13. Kalafat E, Heath P, Prasad S, Pat O, Khalil A. COVID-19 Vaccination in Pregnancy. American J Obst Gyne, 2022;227(2):136-147. https://doi.org/10.1016/j.ajog.2022.05.020
  14. Anderson E, Brigden A, Davies A, Shepherd E, Ingram J. Maternal Vaccines during the Covid-19 Pandemic: A Qualitative Interview Study with UK Pregnant Women. Midwifery, 2021;100:103062. https://doi.org/10.1016/j.midw.2021.103062
  15. Vaccination Considerations for People who are Pregnant or Breastfeeding. Centers for Disease Control and Prevention (CDC), 2019. Available from: https://www.cdc.gov/coronavirus/2019ncov/vaccines/recommendations/pregnancy.html. [cited 2022 Nov 6]
  16. Practice Advisory: Novel Coronavirus 2019. American College of Obstetrics and Gynecologists (ACOG), 2020. Available from: https://www.acog.org/Clinical-Guidance-andPublications/Practice-Advisories/Practice-Advisory-Novel-Coronavirus2019 [cited 2022 Nov 1]
  17. COVID-19 Vaccines, Pregnancy and Breastfeeding. Royal College of Obstetricians and Gynaecologists (RCOG). Available from: https://www.rcog.org.uk/en/guidelines-research-services/coronavirus-covid-19-pregnancy-and-womens-health/covid-19-vaccines-and-pregnancy/covid-19vaccines [cited 2022 Nov 7]
  18. Clinical Management of Severe Acute Respiratory Infection (SARI) when COVID-19 Disease is Suspected. Interim guidance. World Health Organization (WHO), 2020. Available from: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratoryinfectionwhen- novel-coronavirus-(ncov)-infection-is-suspected [cited 2022 Nov 7]
  19. Uludağ E, Serçekuş P, Yıldırım DF, Özkan S. A Qualitative Study of Pregnant Women's Opinions on COVID-19 Vaccines in Turkiye. Midwifery, 2022;114:103459. https://doi.org/10.1016/j.midw.2022.103459
  20. Braun V, Clarke V, Weate P. Using Thematic Analysis in Sport and Exercise Research. Editors Smith B, Sparkes AC. In Routledge Handbook of Qualitative Research in Sport and Exercise. London: Routledge, 2016:191-205.
  21. Neubauer BE, Witkop CT, Varpio L. How Phenomenology can Help us Learn from the Experiences of Others. Persp Med Educ, 2019;8(2):90-97. https://doi.org/10.1007/s40037-019-0509-2
  22. O’Brien BC, Harris IB, Beckman TJ, Reed DA, Cook DA. Standards for Reporting Qualitative Research: A Synthesis of Recommendations. Acade Med, 2014;89(9):1245-1251. https://doi.org/10.1097/ACM.0000000000000388
  23. Byrne D. A Worked Example of Braun and Clarke’s Approach to Reflexive Thematic Analysis. Quality & Quantity, 2022;56(3):1391-1412. https://doi.org/10.1007/s11135-021-01182-y
  24. Sanders J, Blaylock R. “Anxious and Traumatised”: Users’ Experiences of Maternity Care in the UK during the COVID-19 Pandemic. Midwifery. 2021;102:103069. https://doi.org/10.1016/j.midw.2021.103069
  25. Kuckartz U, Rädiker S. Analyzing Qualitative Data with MAXQDA: Text, Audio, and Video. Switzerland: Springer, 2019.
  26. Blakeway H, Prasad S, Kalafat E, Heath PT, Ladhani SN, Le Doare K, Magee LA, O'Brien P, Rezvani A, von Dadelszen P, Khalil A. COVID-19 Vaccination during Pregnancy: Coverage and Safety. Am J Obstet Gynecol, 2022;226(2):236.e1-236.e14. https://doi.org/10.1016/j.ajog.2021.08.007
  27. Nakahara A, Biggio JR, Elmayan A, Williams FB. Safety-Related Outcomes of Novel mRNA COVID-19 Vaccines in Pregnancy. Am J Perinatol, 2022;39(13): 1484-1488. https://doi.org/ 10.1055/a-1745-1168
  28. Wainstock T, Yoles I, Sergienko R, Sheiner E. Prenatal Maternal COVID-19 Vaccination and Pregnancy Outcomes. Vaccine, 2021;39(41):6037-6040. https://doi.org/10.1016/j.vaccine.2021.09.012
  29. Dollinger S, Zlatkin R, Jacoby C, Shmueli A, Barbash-Hazan S, Chen R, Danieli HZ, Sukenik S, Hadar E, Wiznitzer A. Clinical Characteristics and Outcomes of COVID-19 During Pregnancy-a Retrospective Cohort Study. Reprod Sci, 2022;29(8):2342-2349. https://doi.org/10.1007/s43032-022-00949-4
  30. Dileep A, ZainAlAbdin S, AbuRuz S. Investigating the Association between Severity of COVID-19 Infection during Pregnancy and Neonatal Outcomes. Scientific Reports, 2022;12(1): 3024. https://doi.org/10.1038/s41598-022-07093-8
  31. Pairat K, Phaloprakarn C. Acceptance of COVID-19 Vaccination during Pregnancy among Thai Pregnant Women and their Spouses: A Prospective Survey. Reprod Health, 2022;19(1):74. https://doi.org/10.1186/s12978-022-01383-0